While V1aR-deficient mice represent a valuable model for improved understanding of VP biology, detailed characterization of effects elicited by selective V1aR agonists and antagonists in rodent models of DM2 and DKD is of immediate clinical relevance (37). This evidence concerns the gene AVPR1A and myotonic dystrophy type 2.